Antimicrobial agents are most often tested against bacteria in the log phase of multiplication to produce the maximum bactericidal effect. In an infection, bacteria may multiply less optimally. We examined the effects of several classes of antimicrobial agents to determine their actions on gram-positive and gram-negative bacteria during nongrowing and slowly growing phases. Only ciprofloxacin and ofloxacin exhibited bactericidal activity against nongrowing gram-negative bacteria, and no antibiotics were bactericidal (3-order-of-magnitude killing) against Staphylococcus aureus. For the very slowly growing gram-negative bacteria studied, gentamicin (an aminoglycoside), imipenem (a carbapenem), meropenem (a carbapenem), ciprofloxacin (a fluoroquinolone), and ofloxacin (a fluoroquinolone) exhibited up to 5.7 orders of magnitude more killing than piperacillin or cefotaxime. This is in contrast to optimally growing bacteria, in which a wide variety of antibiotic classes produced 99.9% killing. For the gram-positive and gram-negative bacteria we examined, antibiotic king was greatly dependent on the growth rate. The clinical implications of slow killing by chemotherapeutic agents for established bacterial infections and infections involving foreign bodies are unknown.
The effectiveness of an antimicrobial agent is measured by its ability to inhibit and kill bacteria. However, tests of this ability are usually performed on log-phase bacteria or those in a very rapid-growth phase in media supplying all of the necessary nutrients for optimal growth (11) . Clinically, microorganisms in some infected tissues may be walled off quickly by host leukocytes, followed by fibrin deposits, and thus the growth of the bacteria may be less optimal and controlled by the limited access to nutrition (13) . Other evidence for the importance of studying dormant organisms is available. For Staphylococcus epidermidis, Widmer et al. showed that only data on antibiotic killing of static organisms correlated with successful therapy (16) . Isolates of S. aureus from chronic subcutaneous cage infections in rats were shown to be in a state of dormancy (4) . In these scenarios, the organisms multiply at a less-than-optimal rate and the effectiveness or lack of effectiveness of antibiotics against organisms in such a growth state is just being recognized. It is well known that a P-lactam antibiotic exerts its maximum effect on rapidly growing bacteria, but the limits of its activities against nongrowing and slowly growing bacteria need to be defined.
MATERIALS AND METHODS
Bacterial strains and antibiotics. prepared from an overnight growth of colonies on sheep blood tryptic soy agar after they had been thawed from storage in a -70°C freezer. Three to four colonies were inoculated into optimal broth (as defined below for optimalgrowth studies) or suboptimal broth (as defined below for suboptimal-growth studies), and after 4 h of incubation at 35°C, the organisms were diluted with the respective prewarmed liquid culture media to the desired inoculum concentration. Stationary-phase bacteria were grown for 24 h in Mueller-Hinton broth and diluted in warm sterile limiting growth media to the desired inoculum. A high inoculum concentration of 108 CFU/ml was used, similar to the high inoculum concentration used in a chemostat culture of P. aeruginosa with carbapenems (17) . This high inoculum concentration has to be used to avoid the antibiotic carry-over effect (8) when using antibiotics in the achievable blood concentrations, as suggested by the National Committee for Clinical Laboratory Standards (10) .
Media controlling rate of growth. The basic media used were different for gram-positive and gram-negative organisms. For gram-negative bacteria, the three media used were M9 (12) Table   2 ). (Table 3) . Besides this S. aureus strain, we also investigated three clinical strains resistant only to penicillin and found the same lack of killing by antibiotics other than the quinolones.
Killing of slowly growing bacteria. When 1/10 of the carbon source was provided, gram-negative bacteria grew suboptimally. Among the antibiotics tested, several showed good activity. Gentamicin, the two carbapenem antimicrobial agents, and the fluroquinolones produced the best killing responses. The rank order of killing of gram-negative bacteria was generally gentamicin, followed by the two fluoroquinolones, followed by the two carbapenems, which produced Escherichia coli at least 2 orders of magnitude more killing than a broadspectrum penicillin and an aminothiazolyl cephalosporin with inhibitory activity against these organisms. The differences in killing action among the antimicrobial agents were seen at 6 h, and these differences widened at 24 h of incubation. For slowly growing S. aureus, gentamicin and the two quinolones produced the best killing (nearly or greater than 3 orders of magnitude). the antibiotics tested. These findings agree with previous observations on these antibiotics (3, 7). For S. aureus, the two quinolones tested appeared to have the best activity, which is consistent with previous observations (14) . Gentamicin and rifampin appeared to kill optimally growing staphylococci initially, but by 24 h there was regrowth by resistant organisms. Optical density measurements. Initially, optical densities of the organisms were monitored along with viability determination of all of the test samples. In the nongrowing phase, we observed a significant decrease in turbidity without a concomitant decrease in viability in all of the gramnegative bacteria studied. This decrease was seen after the first 6 h and after 24 h of incubation. An example of this is shown in Fig. 2 for E. coli. After this observation, optical density was no longer used as a reliable measurement of bacterial killing.
DISCUSSION
Most antibiotics, especially the older P-lactams, kill bacteria only during the growth phase (15) . During less-thanoptimal growth, a detailed study of a mutant auxotrophic E. coli strain showed that the carbapenem imipenem may offer a substantial measure of bactericidal activity during a 6-h observation (5) . Bactericidal activity was monitored by optical density and bacterial viability. For longer observation periods, a chemostat was used to study antibiotic bactericidal activity for bacteria growing at different rates (6) .
Our observations extend the observations of Tuomanen et al. (5, 15) to nonauxotrophic gram-positive and gram-negative organisms, those that usually infect humans. Under conditions of no growth, we found that only the fluoroquinolones studied showed significant bactericidal activities. At 8 ,ug/ml, gentamicin showed no bactericidal activity. During slow growth, with the growth rate controlled by the amount of the carbon source added, several antibiotics shoWed substantial bactericidal activities. Among these were the two carbapenems studied, imipenem and meropenem.
The clinical significance of the differences observed among the antibiotics for slowly growing or nongrowing bacteria is only speculative. It is known that there are many clinical situations in which the bacteria infecting the host are in a nearly dormant state, and this has recently been proven in an animal model (4). The slow growth or dormant state of the bacteria may be responsible for bacteria escaping the antibiotic effect. In an animal-based surgical stitch model, the killing effects of antibiotics were dramatically reduced by the presence of a foreign body (suture threads) which can harbor organisms in a dormant state (1). S. epidermidis can produce large amounts of slirpe during the late log phase, which can further limit the'aivailability of nutrients to the organism and induce the organism to enter a state of dormancy (2, 9) .
Prosthetic implants are particularly susceptible to chronic colonization, since a protective environment may be available for the contaminating bacteria, thus permitting them to become dormant. Many infections, once established and addressed by a nearly normal host, become indolent and contain nonmultiplying bacteria. These can be encountered clinically in the form of abscesses or small pockets of walled-off infections (13) . In all of these situations, antibiotics with substantial btctericidal activity for nonproliferating bacteria may have an advantage (16) . The in vitro observations presented here need to be studied in an in vivo system to determine whether the differences observed among the antibiotics are clinically valid.
